glutamic acid has been researched along with reboxetine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falcon, R; González, I; Jorquera, F; Monari, M; Orrego, F; Sandoval, M; Sandoval, S; Vargas, F; Wyneken, U | 1 |
| Cowen, PJ; Evans, J; Jezzard, P; Murphy, SE; Selvaraj, S; Taylor, M; Wylezinkska, M | 1 |
| Alen, F; Arco, R; Ballesta, A; Decara, J; Gómez de Heras, R; Orio, L; Pavón, FJ; Ramírez-López, M; Rodríguez de Fonseca, F; Serrano, A; Suárez, J; Vadas, E; Vargas, A | 1 |
| Belloch, FB; Cortés-Erice, M; Díaz-Perdigon, T; Herzog, E; Puerta, E; Tordera, RM; Zhang, XM | 1 |
1 trial(s) available for glutamic acid and reboxetine
| Article | Year |
|---|---|
Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Double-Blind Method; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Morpholines; Occipital Lobe; Reboxetine; Selective Serotonin Reuptake Inhibitors; Young Adult | 2008 |
3 other study(ies) available for glutamic acid and reboxetine
| Article | Year |
|---|---|
Clinically relevant doses of fluoxetine and reboxetine induce changes in the TrkB content of central excitatory synapses.
Topics: Animals; Antidepressive Agents; Blotting, Western; Brain; Brain-Derived Neurotrophic Factor; Dose-Response Relationship, Drug; Fluoxetine; Glutamic Acid; Immunoprecipitation; Male; Morpholines; Phosphotyrosine; rab5 GTP-Binding Proteins; Rats; Rats, Sprague-Dawley; Reboxetine; Receptor, trkB; Subcellular Fractions; Synapses; Time Factors | 2006 |
Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinking.
Topics: Alcoholism; Animals; Drug-Seeking Behavior; Endocannabinoids; Glutamic Acid; Hippocampus; Male; Prefrontal Cortex; Rats; Rats, Wistar; Reboxetine; Self Administration; Signal Transduction; Substance Withdrawal Syndrome | 2021 |
Fast antidepressant action of ketamine in mouse models requires normal VGLUT1 levels from prefrontal cortex neurons.
Topics: Anhedonia; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depression; Disease Models, Animal; Glutamic Acid; Ketamine; Mice; Neurons; Prefrontal Cortex; Reboxetine; Vesicular Glutamate Transport Protein 1 | 2023 |